We turned one! “Too rich for my blood: Obesity, palliative care, hepatitis c”


Originally aired March 11, 2014: obesity, palliative care, hepatitis c

Amol, Fahad, and Travis want you to:
1. Understand trends in obesity prevalence in adults and children.
2. Appreciate the effect of early palliative care on quality of life in patients with advanced cancer.
3. Recognize new therapeutic options in chronic Hepatitis C infection and their associated cost implications.

Continuing medical education

Internists can receive 0.5 hours of Continuing Medical Education credit for each podcast they listen to through the Canadian Society of Internal Medicine (MOC Category 1) and the American Medical Association (PRA Category 1). To receive CME credit for listening to this podcast, please click here to fill out our Evaluation and Impact Assessment Form.

The papers

*Goyal M et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med, 2015 Mar 12;372(11):1019-30. (PubMed).

*Torres A et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015 Feb 17;313(7):677-86. (PubMed).

Ogden C et al. Prevalence of Childhood and Adult Obesity in the United States, 2011-2012. JAMA 2014 Feb 26;311(8):806-14. (PubMed)

Zimmermann C et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 2014 Feb 18. pii: S0140-6736(13)62416-2. (PubMed)

Sulkowski M et al. Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection. NEJM 2014 Jan 16;370(3):211-21. (PubMed)

Good stuff

Fahad – Slow Ideas, Atul Gawande. The New Yorker, July 29, 2013.

Travis – Are we in a Medical Education Bubble Market, David A. Asch et al., NEJM, Nov. 21, 2013.

Amol – The blood harvest, Alex Madrigal. The Atlantic, Feb 26, 2014.

*Amol – Paul Kalanithi, writer and neurosurgeon, dies at 37. Rosanne Spector. Stanford Medicine News Centre.

Question of the week

Can society afford incredibly expensive drugs for common conditions?

Leave a Comment